Activity Survey

The APBMT Activity Survey has been performed since 2007.
The following figure shows how the data was collected.

Data collection.png

The way of submission is different in each country/region.
From the countries/regions which have a national registry, data is submitted through the national registries. From the countries/regions which do not have a national registry, data is submitted through the regional persons in charge who collect data from major transplant centers or through major transplant centers directly.

 

 

The result of Activity Survey 2020 (HSCT performed in 2019)

1.Total number of HSCTs.png

The No. of HSCTs are increasing year by year.

In 2019, that exceeded twenty-seven-thousand in Asia- Pacific region.

 

 

2.Number of HSCTs and centers.png

21 countries and seven-hundred-three centers cooperated with our Activity Survey.

We appreciate about 40 cooperators made effort collecting this survey.

 

3.All HSCTs by country(over 1000HSCTs).png

 

4.All HSCTs by country(100-1000HSCTs).png

 

5.All HSCTs by country(under100HSCTs).png

 

In 2019, Australia:1872, Bangladesh:20, China:11367, HongKong:152, India:2432, Indonesia:5, Iran:1080, Japan:5860, Korea:2707, Malaysia:188, Mongolia:6, Myanmar:6, Nepal:25, NewZealand:301, Pakistan:177, Philippines:44, Singapore:244, SriLanka:73, Taiwan:390, Thailand:342, and Vietnam:103 HSCTs performed.

 

6.Main indication.png

The pie chart showing the Main indication of HSCTs in Asia-Pacific area.

AML accounts for more than 20 percent, Plasma Cell Disorder: 18%, Lymphoid malignancy: 15%,and ALL : 14%. These top 4 indication accounts three fourth of the whole.

7.Disease types year by year (over 1000).png

The top 6 disease indications are AML, Multiple Myeloma, Lymphoid malignancy, ALL, MDS, and Aplastic anemia.

 

8.Disease types year by year (100- 1000).PNG

9.Disease types year by year (under100).PNG

 

10.Major division of desease types by country.PNG

 

11.Trends in HLA-haploidentical.PNG

No. of Haplo transplant increased rapidly. In 2019, the number of them run up to 6,935.

 

12.Propotion of Haplo in the related transplant by country.PNG

Haplo transplant were performed in many countries.

In China, Myanmar, Nepal, and Philippines, Singapore , SriLanka , Haplo transplant accounts for more than half of related transplant.

 

 

13.Number of total transplants per 10 million population (2019).PNG

 

0.1-100     Bangladesh, China, India, Indonesia, Malaysia, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam

100-300    Hong Kong, and Taiwan

300-500    Japan, and Singapore

more than 500    Australia, New Zealand, and South Korea

 

14.Number of allogeneic transplants per 10 million population (2019).PNG

0.1-50     Bangladesh, India, Indonesia, Malaysia, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam

50-150    China, Iran, and Taiwan

150-200    Hong Kong

more than 200    Australia, Japan, New Zealand, Singapore, and South Korea 

 

 

15.Number of autologous transplants per 10 million population (2019).PNG

0-1     Bangladesh, and Indonesia

1-50    China, Hong Kong, India, Malaysia, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam

50-150    Iran, and Taiwan

150-300  Japan, Singapore, and South Korea

more than 300    Australia, and New Zealand

 

 

16.Number of unrelated transplants per 10 million population (2019).PNG

no UR     Bangladesh, Indonesia, Mongolia, Myanmar, Nepal, Pakistan, and Philippines

0.01-10    India, Iran, Malaysia, Sri Lanka, Thailand, and Vietnam

10-50    China and Taiwan

50-100   Singapore, and Hong Kong

more than 100    Australia, Japan, New Zealand, and South Korea

 

 

Detailed information of APBMT Activity Survey 2020 (HSCT performed in 2019) (PDF). :Members only; need ID, and Password